Clinical Trial Update: Pentoxifylline and Systemic Inflammation in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating pentoxifylline for systemic inflammation in hemodialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hemodialysis
• Inflammation

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Inflammation, End-stage Renal Disease | Phase 4 | Status: COMPLETED